Instrument Inactif

Communiqués Luminex Corporation

Actions

LMNX

US55027E1029

Equipement et technologie médicale avancés

Communiqués

28/07/21	Webinar: Results from a Multi-Antigen Antibody Assay for COVID-19 Research	PU
22/07/21	Luminex : XMAP® INTELLIFLEX Takes Flight	PU
14/07/21	Luminex : Termination of Material Definitive Agreement (Form 8-K)	PU
14/07/21	LUMINEX CORP : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
09/07/21	Luminex : Need to Analyze Extracellular Vesicle Cargo? Flow Cytometry Can Help!	PU
09/07/21	LUMINEX CORP : Other Events (form 8-K)	AQ
08/07/21	Partnering the new xMAP® INTELLIFLEX Platform with Partner Software: 5 Packages to Improve Your Data Analysis	PU
30/06/21	Luminex : New Software Offers a Streamlined User Experience for the xMAP® INTELLIFLEX System	PU
21/06/21	LUMINEX CORP : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	AQ
18/06/21	The Faces of Luminex: Maria Escobar, Global Manufacturing and Quality	PU
16/06/21	Luminex : For Researchers Who Need Flexible Throughput, the Guava® Multi-Antigen Antibody Flow Cytometry Assay is Now Available	PU
11/06/21	Luminex : Merger Agreement (Form 8-K)	PU
11/06/21	LUMINEX CORP : Other Events (form 8-K)	AQ
04/06/21	Luminex : Serial ELISAs Keeping You in the Lab? Switch to Multiplexing and Save	PU
28/05/21	Luminex : Extracellular Vesicles Reimagined with Multiplex Color Detection in Imaging Flow Cytometry	PU
26/05/21	LUMINEX CORP : Other Events (form 8-K)	AQ
21/05/21	Luminex : 5 Ways the New xMAP® INTELLIFLEX System Will Empower Your Research	PU
20/05/21	LUMINEX CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
20/05/21	Luminex Corporation : Declares Second Quarter Cash Dividend	PR
12/05/21	Luminex : Pre-Operative COVID-19 Testing and the Case for Standalone vs. Paneled SARS-CoV-2 Assays	PU
07/05/21	The Faces of Luminex: Wilco de Jager, LTG Field Applications	PU
06/05/21	Luminex: Q1 Earnings Snapshot	AQ
05/05/21	LUMINEX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
28/04/21	Luminex : Why Researchers Love xMAP® Technology	PU
22/04/21	Amnis® AI: Imaging Flow Cytometry Analysis Powered by Deep Learning	PU